ASRS 2023: Proposed Biosimilar Demonstrates Similar Efficacy to Aflibercept for Diabetic Macular Edema
CT-P42 shows similar mean change in best corrected visual acuity from baseline to week 8 and similar safety profile to aflibercept
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.